News Conference News SCCT 2017 Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See? Yael L. Maxwell July 10, 2017
News Conference News SCCT 2017 Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration Yael L. Maxwell July 09, 2017
News Conference News SCCT 2017 Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions Yael L. Maxwell July 08, 2017
News Conference News TVT 2017 Valve Leaflet Thrombosis: Treat It or Leave It Be? Shelley Wood June 19, 2017
News Conference News EuroPCR 2017 If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year Shelley Wood May 17, 2017
News Conference News EAS 2017 Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive Yael L. Maxwell May 01, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News ACC 2017 Does Hormone Replacement Therapy Curb Atherosclerosis? New Imaging Study Opens Old Questions Shelley Wood March 09, 2017
News Conference News CRT 2017 Suspended Lead Curtain, Robotic PCI, Offer Significant Head Protection from Radiation During PCI Michael O'Riordan February 20, 2017
News Conference News ISET 2017 Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients Caitlin E. Cox February 06, 2017
News Conference News AHA 2016 Stress Testing May Be Increasing Among Younger Patients With Commercial Health Insurance L.A. McKeown November 23, 2016
News Conference News TCT 2016 Novel SES Fails to Match Xience EES for Chronic Total Occlusions Yael L. Maxwell November 08, 2016
News Conference News TCT 2016 CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI Yael L. Maxwell November 01, 2016
News Conference News TCT 2016 Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions Michael O'Riordan October 31, 2016
News Conference News PCR London Valves 2016 Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance Shelley Wood September 22, 2016
News Conference News ESC 2016 Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy Todd Neale September 02, 2016
News Conference News ESC 2016 When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis Michael O'Riordan August 31, 2016
News Conference News EuroPCR 2016 As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease Shelley Wood May 18, 2016